As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.

Optiva Inc. (TSX: OPT) ("Optiva") today announced the receipt of the final order of the Ontario Superior Court of Justice (Commercial List) dated ...

A dozen prior leaders of the U.S. Food and Drug Administration — appointed by Republicans and Democrats alike — issued a scathing denunciation of new FDA assertions casting doubt ...